To describe the safety, tolerability and pharmacokinetics of PF-04447943 after administration
of multiple, ascending, oral doses to healthy elderly subjects.
- Evidence or history of clinically significant unstable disease
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: